Conclusion
Chronic otitis externa is often a recalcitrant problem and a challenge
for the attending doctor. A successful management requires investigation
of underlying cause and a strategy equipped with mixture of old and new
therapies. We present a study analysing the potential benefit of
Flixonase® in resistant chronic otitis externa cases.
All patients (100%) who returned to follow up showed cure, having
previously failed with a multitude of conventional management options.
We did have some limitations which we hope could be analysed further
with a more robustly designed study, however the use of fluticasone
propionate is an exciting and potentially important tool in the arsenal
of the otolaryngologist.
Full informed consent was obtained from all patients prior to data
collection. All patient data was anonymised prior to data analysis